NASDAQ · Biotechnology

Oncolytics Biotech Inc. (ONCY) Stock

$0.56 +2.31% NASDAQ: ONCY Healthcare

Valuation

MetricValue
Price$0.56
Market Cap$55.90M
P/E Ratio-2.36
P/B Ratio-15.75
P/S Ratio0.00
EPS (TTM)$-0.41
52-Week High$1.32
52-Week Low$0.53
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE780.00%
ROA-498.10%
ROCE-1450.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.07
Current Ratio1.13

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-26.0M$-20.0M$-25.0M$-26.0M$-29.0M
Net Profit$-26.0M$-18.0M$-21.0M$-23.0M$-29.0M
EPS$-0.49$-0.44$-0.41$-0.30$-0.41
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$46.0M$37.0M$39.0M$20.0M$10.0M
Total Liabilities$10.0M$11.0M$11.0M$14.0M$16.0M
Cash$41.0M$12.0M$35.0M$16.0M$7.0M
Borrowings$1.0M$0$0$1.0M$1.0M

Latest News

Oncolytics Biotech Shares Climb Ahead of Planned FDA Meeting on REO 033 Trial (ONCY) InvestorsHub · Jul 13, 2026 Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial GlobeNewswire · Jul 13, 2026 Sector Update: Healthcare Stocks Ease Late Afternoon MT Newswires · Jun 16, 2026 Sector Update: Healthcare Stocks Advance in Afternoon Trading MT Newswires · Jun 16, 2026 Sector Update: Healthcare MT Newswires · Jun 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-22.0M$-17.0M$-21.0M$-20.0M$-20.0M
Investing Cash Flow$-1.0M$-15.0M$15.0M$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$10.0M$-22.0M$18.0M$-15.0M$-6.0M
Free Cash Flow$-23.0M$-17.0M$-21.0M$-20.0M$-20.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.09
EV / EBITDA-2.05
FCF Yield-35.54%
Quick Ratio1.35
Interest Coverage0.00
Return 1Y-19.12%
Return 3Y-69.02%
Return 5Y-61.44%

Ownership

Insiders Held2.19%
Institutions Held3.31%
Institutions Float Held3.39%
Institutional HolderSharesReport Date
Marshall Wace LLP859,8312026-03-31
Renaissance Technologies, LLC715,8382026-03-31
Sandbox Financial Partners, LLC400,0002026-03-31
Seeds Investor LLC 258,3062026-03-31
Tocqueville Asset Management L.p.149,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATOSAtossa Therapeutics, Inc. $2.44 +0.83% -0.54 $24.34M 0.00%
CLNNClene Inc. $3.86 -0.52% -1.10 $49.32M 0.00%
COYACoya Therapeutics, Inc. $4.95 -0.80% -4.53 $116.11M 0.00%
IMMXImmix Biopharma, Inc. $9.46 +1.83% -11.00 $514.64M 0.00%
MGNXMacroGenics, Inc. $3.74 +5.35% -16.25 $237.73M 0.00%

About Oncolytics Biotech Inc.

Oncolytics Biotech Inc. is led by CEO Jared Kelly, employs 28 people, headquartered in CA, publicly traded since 2001.

Oncolytics Biotech Inc. (ONCY) stock trades at $0.56 with a market capitalization of $55.90M. The stock is valued at a price-to-earnings (P/E) ratio of -2.36, price-to-book of -15.75, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.53 and $1.32, and currently trades 57.6% below its 52-week high.

On profitability, Oncolytics Biotech Inc. generates a return on equity (ROE) of 780.00% — well above the market average, a sign of a high-quality business, return on capital employed of -1450.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides